相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
Pallawi Torka et al.
BLOOD CANCER JOURNAL (2023)
Proapoptotic and immunomodulatory effects of SYK inhibitor entospletinib in combination with obinutuzumab in patients with chronic lymphocytic leukaemia
Vi Lam et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Michael J. Dickinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells
Scott Best et al.
LEUKEMIA (2021)
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1 /PD-1 immunotherapy
Nikolaos Ioannou et al.
BLOOD (2021)
The ubiquitin system: from cell signalling to disease biology and new therapeutic opportunities
Rune Busk Damgaard
CELL DEATH AND DIFFERENTIATION (2021)
NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells
Adam S. Kittai et al.
Oncotarget (2021)
Immunomodulatory Drugs for the Treatment of B Cell Malignancies
Nikolaos Ioannou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition
Sara Petillo et al.
CELL DEATH & DISEASE (2021)
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer
Daniel J. McGrail et al.
CANCER CELL (2020)
Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity
Xiaoqing Jia et al.
CLINICAL CANCER RESEARCH (2019)
Neddylation: a novel modulator of the tumor microenvironment
Lisha Zhou et al.
MOLECULAR CANCER (2019)
Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-kappa B-CCL2 signaling in lung cancer
Lisha Zhou et al.
ONCOGENE (2019)
Histone Deacetylase Inhibition Sensitizes PD1 Blockade-Resistant B-cell Lymphomas
Xiaoguang Wang et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Coffee and pancreatic cancer risk among never-smokers in the UK prospective Million Women Study
Charlie D. Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The ubiquitin ligase SCFFBXW7α promotes GATA3 degradation
Nan Song et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer
Anna E. Kersh et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance
Jinfang Zhang et al.
NATURE (2018)
PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression
Haidong Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Neddylation contributes to CD4(+) T cell-mediated protective immunity against blood-stage Plasmodium infection
Qianqian Cheng et al.
PLOS PATHOGENS (2018)
Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis
Cody Paiva et al.
ONCOTARGET (2017)
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Asis Palazon et al.
CANCER CELL (2017)
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma
Jatin J. Shah et al.
CLINICAL CANCER RESEARCH (2016)
SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses
Nathan D. Mathewson et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study
Ronan T. Swords et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors
K. L. B. Knorr et al.
CELL DEATH AND DIFFERENTIATION (2015)
Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents
C. Paiva et al.
CELL DEATH & DISEASE (2015)
MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells
Yanyan Gu et al.
BLOOD (2014)
The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells
J. Claire Godbersen et al.
CLINICAL CANCER RESEARCH (2014)
Neddylation plays an important role in the regulation of murine and human dendritic cell function
Nathan Mathewson et al.
BLOOD (2013)
Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide
Alan G. Ramsay et al.
BLOOD (2013)
Impaired Proteasome Function Activates GATA3 in T Cells and Upregulates CTLA-4: Relevance for Sezary Syndrome
Heather M. Gibson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
The Discovery of a Reciprocal Relationship between Tyrosine-Kinase Signaling and Cullin Neddylation
Samantha F. Friend et al.
PLOS ONE (2013)
Neddylation pathway regulates T-cell function by targeting an adaptor protein Shc and a protein kinase Erk signaling
Hyung-seung Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth
Zhongguang Luo et al.
CANCER RESEARCH (2012)
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma
Michael A. Milhollen et al.
BLOOD (2010)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter
Heather M. Gibson et al.
JOURNAL OF IMMUNOLOGY (2007)
Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation
Chunxia Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Function and regulation of Cullin-RING ubiquitin ligases
MD Petroski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Molecular basis of the VHL hereditary cancer syndrome
WG Kaelin
NATURE REVIEWS CANCER (2002)
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
F Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
T Kamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
